Bridgett Knox Source Confirmed

OverviewAI-generated summary

Bridgett Knox's research focuses on the pharmacological effects of substances, particularly in the context of drug metabolism and toxicity. She has investigated the role of microRNA regulation in the treatment of steroidogenesis suppression, specifically examining the effects of ketoconazole via CYP17A1 inhibition. Knox also explores the application of microphysiological systems as an in vitro method for evaluating drug absorption, distribution, metabolism, excretion, and toxicity. Her work contributes to understanding the complex interactions of drugs within biological systems and developing alternative methods for preclinical testing.

Knox has published 16 papers, accumulating 404 citations and an h-index of 11. She has collaborated with Shivangi Shrimali at the National Center for Toxicological Research, with whom she shares one publication. Her recent activity indicates ongoing engagement in her field.

Metrics

• h-index: 11
• Publications: 16
• Citations: 404